FDA Inspection 1304024 - Aphena Pharma Solutions-Maryland LLC - February 20, 2026
FDA Inspection 1304024 for Aphena Pharma Solutions-Maryland LLC on February 20, 2026. Classification: Voluntary Action Indicated (VAI).
One-time purchase from the GKS catalog. Lifetime access in your library. Single documents and full company profiles available. All sales final.
FDA Inspection 1304024 for Aphena Pharma Solutions-Maryland LLC on February 20, 2026. Classification: Voluntary Action Indicated (VAI).
Access our comprehensive regulatory intelligence platform to analyze patterns, track compliance trends, and stay ahead of regulatory changes.
Inspection Date
February 20, 2026
Product Type
Drugs
ID: 332b81e8-8ad4-456b-baf2-cf25d9db9ed3
View on DashboardTransform Regulatory Data into Actionable Intelligence
Join leading pharmaceutical and medical device companies who trust GKS for their regulatory compliance needs.
Try KeyPedia Today
Explore our real use cases and discover our features in depth.
Subscribe to our newsletter
Get the latest updates and insights delivered to your inbox